Comments on the poll question "Funding FDA Inspections"
Your comments to the poll question: The proposed Food and Drug Administration Globalization Act of 2008 recommends imposing a fee for inspections to fund the cost of FDA inspections (both domestic and foreign inspections). If such a measure is adopted, how should the fee be assessed?
Your comments
"Regarding inspection fees, one approach for establishing fees would be to assess the actual cost or the average cost for doing the inspections after let’s say 100 inspections at various size manufacturing plants. The FDA could then establish, based on the size of the manufacturing facility, a fixed fee. The larger manufacturing facilities might have a larger fee. Many local governments set their fees based upon a historical average of what it costs to perform the task. The goal is that the local municipality is able to recover their out-of-pocket costs and not make any profit from the fees."
The question
The proposed Food and Drug Administration Globalization Act of 2008 recommends imposing a fee for inspections to fund the cost of FDA inspections (both domestic and foreign inspections). If such a measure is adopted, how should the fee be assessed?
1. On a facility basis, based on the size of the manufacturing facility. 2. On a company basis, based on company revenues. 3. On a company basis, based on the number of manufacturing facilities operated by the company. 4. A flat fee for all companies with pharmaceutical manufacturing facilities.
Click here to submit a comment. Go to the poll archive to see past questions and results.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Article
Comments on the poll question "Funding FDA Inspections"
Your comments to the poll question: The proposed Food and Drug Administration Globalization Act of 2008 recommends imposing a fee for inspections to fund the cost of FDA inspections (both domestic and foreign inspections). If such a measure is adopted, how should the fee be assessed?
Your comments
The question
The proposed Food and Drug Administration Globalization Act of 2008 recommends imposing a fee for inspections to fund the cost of FDA inspections (both domestic and foreign inspections). If such a measure is adopted, how should the fee be assessed?
1. On a facility basis, based on the size of the manufacturing facility.
2. On a company basis, based on company revenues.
3. On a company basis, based on the number of manufacturing facilities operated by the company.
4. A flat fee for all companies with pharmaceutical manufacturing facilities.
Click here to submit a comment. Go to the poll archive to see past questions and results.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications
Drug Solutions Podcast: Sustainable Solutions for Biopharma
Bringing novel ADC formats into the clinic
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
BETTER, FASTER SMALL-MOLECULE SYNTHESIS: LEVERAGING MODERN TOOLS TO EVALUATE AND OPTIMIZE PROCESS CHEMISTRY
Competition in MASH is Heating Up as GLP-1s Gate-Crash the Party
Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications
Drug Solutions Podcast: Sustainable Solutions for Biopharma
Bringing novel ADC formats into the clinic
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
BETTER, FASTER SMALL-MOLECULE SYNTHESIS: LEVERAGING MODERN TOOLS TO EVALUATE AND OPTIMIZE PROCESS CHEMISTRY
Competition in MASH is Heating Up as GLP-1s Gate-Crash the Party